Biogen (BIIB) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.62.
- Biogen's Equity Ratio rose 406.0% to 0.62 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.62, marking a year-over-year increase of 406.0%. This contributed to the annual value of 0.62 for FY2025, which is 406.0% up from last year.
- According to the latest figures from Q4 2025, Biogen's Equity Ratio is 0.62, which was up 406.0% from 0.62 recorded in Q3 2025.
- In the past 5 years, Biogen's Equity Ratio ranged from a high of 0.62 in Q3 2025 and a low of 0.45 during Q1 2021
- For the 5-year period, Biogen's Equity Ratio averaged around 0.54, with its median value being 0.56 (2023).
- In the last 5 years, Biogen's Equity Ratio tumbled by 687.14% in 2021 and then skyrocketed by 2152.64% in 2023.
- Biogen's Equity Ratio (Quarter) stood at 0.46 in 2021, then grew by 18.79% to 0.55 in 2022, then rose by 1.11% to 0.55 in 2023, then increased by 8.1% to 0.6 in 2024, then grew by 4.06% to 0.62 in 2025.
- Its Equity Ratio stands at 0.62 for Q4 2025, versus 0.62 for Q3 2025 and 0.62 for Q2 2025.